HUE069249T2 - Kombinációs terápia rák kezelésére - Google Patents

Kombinációs terápia rák kezelésére

Info

Publication number
HUE069249T2
HUE069249T2 HUE21794474A HUE21794474A HUE069249T2 HU E069249 T2 HUE069249 T2 HU E069249T2 HU E21794474 A HUE21794474 A HU E21794474A HU E21794474 A HUE21794474 A HU E21794474A HU E069249 T2 HUE069249 T2 HU E069249T2
Authority
HU
Hungary
Prior art keywords
combination therapy
treating cancer
cancer
treating
therapy
Prior art date
Application number
HUE21794474A
Other languages
English (en)
Inventor
Elisabetta Leo
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUE069249T2 publication Critical patent/HUE069249T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE21794474A 2020-10-08 2021-10-07 Kombinációs terápia rák kezelésére HUE069249T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063089195P 2020-10-08 2020-10-08

Publications (1)

Publication Number Publication Date
HUE069249T2 true HUE069249T2 (hu) 2025-02-28

Family

ID=78293953

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE21794474A HUE069249T2 (hu) 2020-10-08 2021-10-07 Kombinációs terápia rák kezelésére

Country Status (19)

Country Link
US (1) US20230372333A1 (hu)
EP (1) EP4225297B1 (hu)
JP (1) JP7818585B2 (hu)
KR (1) KR20230083291A (hu)
CN (1) CN116194110B (hu)
AU (1) AU2021356123B2 (hu)
BR (1) BR112023005160A2 (hu)
CA (1) CA3197056A1 (hu)
DK (1) DK4225297T3 (hu)
ES (1) ES3005507T3 (hu)
FI (1) FI4225297T3 (hu)
HU (1) HUE069249T2 (hu)
IL (1) IL301687A (hu)
MX (1) MX2023004156A (hu)
PL (1) PL4225297T3 (hu)
PT (1) PT4225297T (hu)
TW (1) TW202228693A (hu)
WO (1) WO2022074124A1 (hu)
ZA (1) ZA202304965B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202304911A (zh) * 2021-04-23 2023-02-01 大陸商南京明德新藥研發有限公司 吡啶醯胺類化合物
WO2023036285A1 (zh) * 2021-09-09 2023-03-16 南京奥利墨斯医药科技有限公司 一种杂芳环类化合物及其应用
US20230250428A1 (en) * 2022-02-07 2023-08-10 Alliance Of Cardiovascular Researchers Method and composition for early detection of malignancies
IL316019A (en) * 2022-04-07 2024-11-01 Astrazeneca Ab Combined treatment for cancer
CA3254948A1 (en) * 2022-04-07 2023-10-12 Astrazeneca Ab Polytherapy for the treatment of cancer
CN121464135A (zh) * 2023-07-07 2026-02-03 优领医药科技(香港)有限公司 含哌嗪并环类衍生物的晶型、其盐型、其制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6648040B2 (ja) * 2014-05-28 2020-02-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 がん治療のための併用療法としてのエリブリン及びポリ(adpリボース)ポリメラーゼ(parp)阻害剤の使用
TWI837403B (zh) * 2019-07-19 2024-04-01 瑞典商阿斯特捷利康公司 化學化合物

Also Published As

Publication number Publication date
ES3005507T3 (en) 2025-03-14
DK4225297T3 (da) 2025-01-02
KR20230083291A (ko) 2023-06-09
PT4225297T (pt) 2024-12-30
EP4225297A1 (en) 2023-08-16
JP2023546362A (ja) 2023-11-02
FI4225297T3 (fi) 2024-12-10
US20230372333A1 (en) 2023-11-23
WO2022074124A1 (en) 2022-04-14
AU2021356123B2 (en) 2025-01-09
CA3197056A1 (en) 2022-04-14
EP4225297B1 (en) 2024-10-23
ZA202304965B (en) 2024-09-25
TW202228693A (zh) 2022-08-01
CN116194110B (zh) 2025-06-17
PL4225297T3 (pl) 2025-03-17
CN116194110A (zh) 2023-05-30
MX2023004156A (es) 2023-05-03
IL301687A (en) 2023-05-01
AU2021356123A1 (en) 2023-06-08
BR112023005160A2 (pt) 2023-04-18
JP7818585B2 (ja) 2026-02-20

Similar Documents

Publication Publication Date Title
IL304275A (en) Cancer treatment methods
IL312680A (en) Cancer treatment methods
PL4225297T3 (pl) Terapia skojarzona w leczeniu nowotworu złośliwego
IL307964A (en) Combined treatment for cancer
IL281439A (en) Combined treatment for blood cancer
ZA202310076B (en) Combination therapies for treating cancer
IL316016A (en) Combined treatment for cancer
IL316017A (en) Combined treatment for cancer
IL314713A (en) Combined therapy for colorectal carcinoma
IL304436A (en) Cancer treatment
IL288178A (en) Combined gmci and ddri treatment for cancer
GB202301902D0 (en) Combination therapy for cancer
IL317573A (en) Combination therapy for cancer treatment
IL316019A (en) Combined treatment for cancer
GB202218395D0 (en) Cancer therapy
EP4313029A4 (en) COMBINATION THERAPY FOR CANCER TREATMENT
IL305777A (en) Medical combination for cancer treatment
GB202001963D0 (en) Cancer therapy
GB202116680D0 (en) Combination therapy for cancer
GB202103673D0 (en) Combination therapy for cancer
IL326216A (en) Combination therapy for treating prostate cancer
HK40107047A (en) Therapeutic combination for treating cancer
GB202208893D0 (en) Combination therapy for cancer
IL317472A (en) Arbecycline for cancer treatment
GB202303784D0 (en) Cancer treatment